Cytotoxic Effects of 27 Anticancer Drugs in HeLa and MDR1-Overexpressing Derivative Cell Lines.
-
- Takara Kohji
- Department of Hospital Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University
-
- Sakaeda Toshiyuki
- Department of Hospital Pharmacy, School of Medicine, Kobe University
-
- Yagami Tatsurou
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
- Kobayashi Hironao
- Shionogi Research Laboratories, Shionogi & Co., Ltd.
-
- Ohmoto Nobuko
- Department of Hospital Pharmacy, School of Medicine, Kobe University
-
- Horinouchi Masanori
- Department of Hospital Pharmacy, School of Medicine, Kobe University
-
- Nishiguchi Kohshi
- Department of Hospital Pharmacy, School of Medicine, Kobe University
-
- Okumura Katsuhiko
- Department of Hospital Pharmacy, School of Medicine, Kobe University
Search this article
Description
The cytotoxic effects of 27 anticancer drugs including amrubicin, vinorelbine, paclitaxel, docetaxel, gemcitabine, and irinotecan were evaluated in human cervical carcinoma HeLa cells, and drug-resistant HeLa-derived Hvr1-1, Hvr10-6, and Hvr100-6 cells, which were newly established by stepwise exposure to vinblastine. FACS and RT-PCR analysis indicated that MDR1 (P-glycoprotein) was induced without any alterations in expression of its related transporters. Hvr100-6 cells showed 2- to 200-fold higher resistance to anthracyclines than HeLa cells, and unexpectedly showed slight resistance to idarubicin and amrubicin. The relative resistance to vinca-alkaloids was 300- to 600000-fold, and Hvr100-6 cells showed the highest relative resistance to vinorelbine. Hvr100-6 cells also showed 4000- and 60000-fold resistance to the taxanes paclitaxel and docetaxel, respectively. Hvr100-6 cells were also resistant to 6-mercaptopurine, actinomycin D, etoposide, and mitomycin C, with relative resistance of 8-, 45000-, 12-, and 9-fold, respectively. In contrast, Hvr100-6 cells showed no or slight resistance to platinum derivatives, pyrimidine analogues, and alkylating agents or to irinotecan and its active form, or tamoxifen. The cytotoxicity of anthracyclines, vinca-alkaloids, taxanes, actinomycin D, and etoposide was extensively reversed by cyclosporin A. Cyclosporin A had no effect on the cytotoxicity of 6-mercaptopurine or mitomycin C, suggesting that resistance to these drugs was not mediated via MDR1. The alterations in cytotoxicity by overexpression of MDR1 and effects of cyclosporin A could be also qualitatively explained by [3H]vinblastine uptake experiments. The 27 anticancer drugs analyzed here could be classified into substrates and nonsubstrates for MDR1. This will be useful for designing effective regimens for chemotherapy.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 25 (6), 771-778, 2002
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679604923392
-
- NII Article ID
- 110003638755
-
- NII Book ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD38XkvV2gsrY%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 6175089
-
- PubMed
- 12081145
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed